Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pfizer Inc.

Community Practice Connections™: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting


Release Date: August 31, 2018
Expiration Date: August 31, 2019
Media: Internet - based

Activity Overview

Community Practice Connections: Transforming Treatment Paradigms in Renal Cell Carcinoma: Understanding the Role of Risk Stratification and Emerging Data in the Adjuvant Setting consists of a series of interactive clinical vignettes, short video interviews with leading experts in renal cell carcinoma (RCC), and short summaries of clinical data related to these issues. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Pfizer Inc.

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “educational content/video files” will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational program is directed toward urologists, medical oncologists, surgical oncologists, and radiation oncologists interested in the treatment of RCC. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with RCC are also invited to participate.

Learning Objectives

Upon completion of this activity, you should be better prepared to:

  • Substantiate treatment decisions in the management of RCC at key decision points along the disease continuum, based on the most pertinent clinical trial evidence for targeted therapy
  • Integrate knowledge of patient selection and single-agent and combination strategies in the context of mechanisms of action, kinetics of response, best practices in monitoring, and key information that informs adjuvant treatment in the care of patients with RCC
  • Manage treatment-related toxicities as a component of therapeutic decision making in adjuvant treatment settings for patients with RCC
  • Evaluate recent clinical trial data, key ongoing trials, and how emerging adjuvant strategies may further impact the RCC treatment landscape


Robert A. Figlin, MD, FACP
Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Director, Division of Hematology/Oncology
Deputy Director, Integrated Oncology Service Line
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, CA

Disclosure: Grant/Research Support: Peloton, Bristol-Myers Squibb, Argos, Exelixis, Calithera, Merck; Consultant: Johnson & Johnson, CBT, Pfizer, Acceleron, Bristol-Myers Squibb

Allan J. Pantuck, MD, MS, FACS
Professor of Urology
Executive Chair, Medical Institutional Review Board
Vice Chair, Academic Affairs
Director, Urologic Oncology Fellowship
UCLA Institute of Urologic Oncology
Department of Urology
David Geffen School of Medicine at UCLA
Los Angeles, CA

Disclosure: Consultant:  Pfizer

Alain Ravaud, MD, PhD
Professor of Medical Oncology
Head, Department of Medical Oncology
Bordeaux University Hospital
Bordeaux, France

Disclosure: Consultant/Advisory Board: Pfizer, Novartis, Bristol-Myers Squibb, Roche, Ipsen; Other:  Transportation and housing for meetings or conferences: Pfizer, Bristol-Myers Squibb, AstraZeneca

Cora N. Sternberg, MD, FACP
Chief, Department of Medical Oncology
San Camillo and Forlanini Hospitals
Rome, Italy

Disclosure: Consultant: Bristol-Myers Squibb, Pfizer, Ipsen

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).
Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Become a Member

Forgot Password?
Calendar of Events
Filter By